Main Article Content
To find out the use of Prostaglandin F2 alpha to avoid the surgical control of primary
Material and Methods:
This was a Quasi-Experimental study carried out in obstetrics & gynecology unit
B of Khyber Teaching Hospital Peshawar from 1st July 2003 – 30th June 2004. 50 patients having primary
post partum hemorrhage due to uterine atony not responding to conventional oxytocics were given systemic
and local prostaglandin F2 alpha. Vital signs, estimated blood loss and effect on uterine muscular tone
were noted before & after prostaglandin F2 alpha. Surgical interventions were used in patients with
continuous profuse vaginal bleeding despite maximum dose of prostaglandin F2 alpha and/ or
hemodynamic instability of the patients. A semi-structured proforma was used to collect the data.
A total of 44 (88%) patients responded well to the drug. Estimated blood loss before
prostaglandin F2 alpha was 1000 - 4000ml with mean of 2250.00 + 686.98ml as compared to 416.00 +
294.41ml after prostaglandin F2 alpha was used. Side effects of the drug were mostly self limiting and
required symptomatic treatment. No maternal death was recorded.
Prostaglandin F2 alpha is an effective drug to control Primary post partum hemorrhage due
to uterine atony and avoids surgical interventions in most of the patients. Side effects are minimum, most
of which are self limiting.
postpartum hemorrhage due to uterine atony and the adverse effects associated with prostaglandin F2
Work published in JPMI is licensed under a
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.